東阿阿膠(000423.SZ):終止回購公司股份 已回購3.5億元股份
格隆匯6月12日丨東阿阿膠(000423.SZ)公佈,2019年6月24日,公司首次通過股票回購專用證券賬户以集中競價交易方式回購公司股份。截至公告日,公司通過回購專用證券賬户以集中競價交易方式累計回購股份約1004.47萬股,佔公司總股本的1.54%,其中最高成交價為40.11元/股,最低成交價為30.78元/股,合計支付的總金額為人民幣約3.5億元(不含交易費用)。
由於新冠肺炎疫情影響,結合公司實際經營情況,為更好發揮資金在生產經營中的最大作用,以爭取更好業績為股東創造更大價值,經慎重考慮決定終止實施此次回購公司股份事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.